Profile change history

What changed for Cetrorelix?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Cetrorelix identity.

56Total events
56Record additions
0Version changes
18Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 56 connected records →

Showing the latest 56 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

ClinicalTrials.gov record NCT00244452

PeptideScanner retained ClinicalTrials.gov record NCT00244452 at 2026-11-15T22:02:39.332Z. Its registry update date was 2008-03-31, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
March 31, 2008
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00439829

PeptideScanner retained ClinicalTrials.gov record NCT00439829 at 2026-11-15T22:02:39.332Z. Its registry update date was 2010-05-25, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
May 25, 2010
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00628121

PeptideScanner retained ClinicalTrials.gov record NCT00628121 at 2026-11-15T22:02:39.332Z. Its registry update date was 2008-03-04, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
March 4, 2008
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00667758

PeptideScanner retained ClinicalTrials.gov record NCT00667758 at 2026-11-15T22:02:39.332Z. Its registry update date was 2012-08-06, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
August 6, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00746031

PeptideScanner retained ClinicalTrials.gov record NCT00746031 at 2026-11-15T22:02:39.332Z. Its registry update date was 2010-10-25, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
October 25, 2010
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01109654

PeptideScanner retained ClinicalTrials.gov record NCT01109654 at 2026-11-15T22:02:39.332Z. Its registry update date was 2014-07-16, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
July 16, 2014
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01112358

PeptideScanner retained ClinicalTrials.gov record NCT01112358 at 2026-11-15T22:02:39.332Z. Its registry update date was 2018-08-28, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
August 28, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01185704

PeptideScanner retained ClinicalTrials.gov record NCT01185704 at 2026-11-15T22:02:39.332Z. Its registry update date was 2014-02-13, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
February 13, 2014
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01225835

PeptideScanner retained ClinicalTrials.gov record NCT01225835 at 2026-11-15T22:02:39.332Z. Its registry update date was 2014-03-14, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
March 14, 2014
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01402336

PeptideScanner retained ClinicalTrials.gov record NCT01402336 at 2026-11-15T22:02:39.332Z. Its registry update date was 2017-10-10, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
October 10, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01457703

PeptideScanner retained ClinicalTrials.gov record NCT01457703 at 2026-11-15T22:02:39.332Z. Its registry update date was 2017-01-12, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
January 12, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01565265

PeptideScanner retained ClinicalTrials.gov record NCT01565265 at 2026-11-15T22:02:39.332Z. Its registry update date was 2017-05-01, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
May 1, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02042196

PeptideScanner retained ClinicalTrials.gov record NCT02042196 at 2026-11-15T22:02:39.332Z. Its registry update date was 2019-07-11, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
July 11, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02333253

PeptideScanner retained ClinicalTrials.gov record NCT02333253 at 2026-11-15T22:02:39.332Z. Its registry update date was 2016-01-27, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02640976

PeptideScanner retained ClinicalTrials.gov record NCT02640976 at 2026-11-15T22:02:39.332Z. Its registry update date was 2015-12-29, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
December 29, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02784457

PeptideScanner retained ClinicalTrials.gov record NCT02784457 at 2026-11-15T22:02:39.332Z. Its registry update date was 2016-05-27, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
May 27, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02892942

PeptideScanner retained ClinicalTrials.gov record NCT02892942 at 2026-11-15T22:02:39.332Z. Its registry update date was 2026-04-03, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
April 3, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03291821

PeptideScanner retained ClinicalTrials.gov record NCT03291821 at 2026-11-15T22:02:39.332Z. Its registry update date was 2020-12-29, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
December 29, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03759301

PeptideScanner retained ClinicalTrials.gov record NCT03759301 at 2026-11-15T22:02:39.332Z. Its registry update date was 2019-06-24, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
June 24, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04414748

PeptideScanner retained ClinicalTrials.gov record NCT04414748 at 2026-11-15T22:02:39.332Z. Its registry update date was 2025-05-31, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
May 31, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04418908

PeptideScanner retained ClinicalTrials.gov record NCT04418908 at 2026-11-15T22:02:39.332Z. Its registry update date was 2020-06-05, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
June 5, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05326087

PeptideScanner retained ClinicalTrials.gov record NCT05326087 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05767086

PeptideScanner retained ClinicalTrials.gov record NCT05767086 at 2026-11-15T22:02:39.332Z. Its registry update date was 2024-10-15, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
October 15, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05951400

PeptideScanner retained ClinicalTrials.gov record NCT05951400 at 2026-11-15T22:02:39.332Z. Its registry update date was 2026-04-15, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
April 15, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06378268

PeptideScanner retained ClinicalTrials.gov record NCT06378268 at 2026-11-15T22:02:39.332Z. Its registry update date was 2026-03-20, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
March 20, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06608186

PeptideScanner retained ClinicalTrials.gov record NCT06608186 at 2026-11-15T22:02:39.332Z. Its registry update date was 2025-01-22, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
January 22, 2025
Evidence lane
Clinical trials
Record added

Federal Register notice E6-9031

The Federal Register published notice E6-9031, attributed to FDA and its parent HHS department, on 2006-06-09. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; CETROTIDE,” and PeptideScanner's exact reviewed identity mapping connects the document to Cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
June 9, 2006
Evidence lane
Regulatory
Record added

[Medical treatment of uterine fibroids with the LHRH antagonist: Cetrorelix].

PubMed lists PMID 10605180 in Contraception, fertilite, sexualite (1992) as Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1999-10 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 29, 2013
Evidence lane
Literature metadata
Record added

The LHRH antagonist cetrorelix: a review.

PubMed lists PMID 10972520 in Human reproduction update as Journal Article, Review, with publication-date metadata of 2000 Jul-Aug (source-text precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 13, 2019
Evidence lane
Literature metadata
Record added

Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'?

PubMed lists PMID 12151431 in Human reproduction (Oxford, England) as Clinical Trial, Clinical Trial, Phase II, Journal Article, with publication-date metadata of 2002-08 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 13, 2019
Evidence lane
Literature metadata
Record added

[Use of GnRH antagonists (cetrorelix) in assisted reproduction: first report in Mexican literature].

PubMed lists PMID 12448050 in Ginecologia y obstetricia de Mexico as Comparative Study, English Abstract, Journal Article, with publication-date metadata of 2002-09 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 29, 2013
Evidence lane
Literature metadata
Record added

Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.

PubMed lists PMID 13678723 in Gynecologic oncology as Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, and 1 more PubMed publication type, with publication-date metadata of 2003-09 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 27, 2019
Evidence lane
Literature metadata
Record added

Adsorption of the decapeptide Cetrorelix depends both on the composition of dissolution medium and the type of solid surface.

PubMed lists PMID 14757490 in European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2004-02 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 8, 2019
Evidence lane
Literature metadata
Record added

Development and validation of a HPLC method for routine quantification of the decapeptide Cetrorelix in liposome dispersions.

PubMed lists PMID 15019030 in Journal of pharmaceutical and biomedical analysis as Journal Article, Validation Study, with publication-date metadata of 2004-03-10 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 10, 2019
Evidence lane
Literature metadata
Record added

Cetrorelix in the treatment of female infertility and endometriosis.

PubMed lists PMID 17020439 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-10 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 17, 2019
Evidence lane
Literature metadata
Record added

In vivo biodistribution of an androgen receptor avid PET imaging agent 7-alpha-fluoro-17 alpha-methyl-5-alpha-dihydrotestosterone ([(18)F]FMDHT) in rats pretreated with cetrorelix, a GnRH antagonist.

PubMed lists PMID 17934727 in European journal of nuclear medicine and molecular imaging as Journal Article, Research Support, N.I.H., Extramural, with publication-date metadata of 2007-10-13 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 20, 2021
Evidence lane
Literature metadata
Record added

Modification of the in vitro release profile of Cetrorelix by complexation with biophilic partners.

PubMed lists PMID 18855603 in Current drug delivery as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-10 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 11, 2019
Evidence lane
Literature metadata
Record added

Fluorescence spectroscopic determination of the critical aggregation concentration of the GnRH antagonists Cetrorelix, Teverelix and Ozarelix.

PubMed lists PMID 20514551 in Journal of fluorescence as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-06-01 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 20, 2021
Evidence lane
Literature metadata
Record added

A pilot study to assess the use of the gonadotrophin antagonist cetrorelix in preserving ovarian function during chemotherapy.

PubMed lists PMID 21810087 in The Australian & New Zealand journal of obstetrics & gynaecology as Journal Article, with publication-date metadata of 2011-08-02 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Use of cetrorelix in the investigation of testosterone excess in a postmenopausal woman.

PubMed lists PMID 22696667 in BMJ case reports as Case Reports, Journal Article, with publication-date metadata of 2011-04-26 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 21, 2021
Evidence lane
Literature metadata
Record added

Hepatic in vitro metabolism of peptides; Comparison of human liver S9, hepatocytes and Upcyte hepatocytes with cyclosporine A, leuprorelin, desmopressin and cetrorelix as model compounds.

PubMed lists PMID 33548873 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2021-01-27 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 17, 2021
Evidence lane
Literature metadata
Record added

Identification and structural elucidation of a new cetrorelix methylene dimer impurity in cetrorelix acetate by using LC-MS/MS.

PubMed lists PMID 33611089 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2021-02-03 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 17, 2021
Evidence lane
Literature metadata
Record added

Extrahepatic in vitro metabolism of peptides; comparison of human kidney and intestinal S9 fraction, human plasma and proximal tubule cells, using cyclosporine A, leuprorelin, and cetrorelix as model…

PubMed lists PMID 36630767 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2022-12-31 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Cetrorelix in reproductive medicine.

PubMed lists PMID 37223762 in F&S reports as Journal Article, with publication-date metadata of 2022-11-21 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 18, 2024
Evidence lane
Literature metadata
Record added

Synthesis of Diastereomerically Pure Cetrorelix Acetate by Using Fmoc Solid-Phase Peptide Synthesis (SPPS) Strategy: A Commercially Viable Approach.

PubMed lists PMID 40386934 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, with publication-date metadata of 2025-06 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Comparison of Chitosan-Poloxamer Nanoparticles and Poloxamer-based In-Situ Forming Gel for Nose-to-Brain Delivery of Cetrorelix: In Vitro and Pharmacokinetic Studies in Rats.

PubMed lists PMID 42243608 in AAPS PharmSciTech as Journal Article, Comparative Study, with publication-date metadata of 2026-06-04 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 24, 2026
Evidence lane
Literature metadata
Record added

Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord.

PubMed lists PMID 7531902 in Urology as Clinical Trial, Journal Article, with publication-date metadata of 1995-02 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 14, 2019
Evidence lane
Literature metadata
Record added

Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.

PubMed lists PMID 9363724 in Human reproduction (Oxford, England) as Clinical Trial, Journal Article, with publication-date metadata of 1997-09 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 12, 2019
Evidence lane
Literature metadata
Record added

Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix.

PubMed lists PMID 9688409 in Human reproduction (Oxford, England) as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1998-06 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 12, 2019
Evidence lane
Literature metadata